Supercharging an Entrepreneurial Team to Disrupt the Drug-Delivery Status Quo and Improve Patients’ Lives.

BUSINESS OBJECTIVE:
Help a “start-up” within a Fortune 200 CPG and healthcare company develop the brand, positioning, architecture and communication materials needed to bring its revolutionary drug-delivery system to market in the $141 billion biologic drug category*.

HUMAN-CENTRIC MISSION:
Eliminate the pain, anxiety and other drawbacks of injections in order to help patients enjoy a better quality of life.

OUR APPROACH:

Crystallize and quantitatively vet a winning proposition relevant to three distinct audiences—patients, physicians and payers.
Create brand foundational tools and a trademarked global naming system for the new brand and the product’s unique features.
Build a selling story and marketing materials to excite internal leadership and attract potential pharmaceutical partners.

THE OUTCOME:
Seed created a brand identity and selling strategy that showcased the technology’s huge potential, attracting the interest of a large biopharmaceutical company that ultimately purchased the brand.

Source: https://www.statista.com/statistics/947455/global-subcutaneous-biologics-market/

View all Case Studies

Supercharging an Entrepreneurial Team to Disrupt the Drug-Delivery Status Quo and Improve Patients’ Lives.

let’s grow together!

859.594.(GROW) 4769